Albemarle: Finally Poised For Growth Again

  • Albemarle's Q1'25 results showed resilience with strong cost cuts and adjusted EBITDA despite a cycle low in sales. Lithium prices are unsustainably low, with a return to higher prices needed to grow long-term supply to meet ultimate demand levels. The stock is at a prime valuation of 3x EV/EBITDA targets, based on lithium returning to just Q4'23 prices.